Enavate Sciences
Overview
Enavate Sciences is a platform dedicated to supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient need. Through the application of capital support and operational experience, Enavate strives to enable and empower a diverse portfolio of therapeutics companies to accelerate innovation.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Braveheart Bio | Nov 2025 | Series A | Co-investor |
| Sionna | Mar 2024 | Series C | Lead |
| Normunity | Jan 2025 | Series B | Lead |
| AirNexis Therapeutics | Jan 2026 | Series A | Co-investor |
| CAMP4 | Jul 2022 | Series B | Lead |
For institutional investors. Book with your work email.
Key People
James Boylan
Chief Executive Officer
Edd Fleming
Executive Vice President, Commercialization
Sai Abhishek
Biotechnology Venture Capital
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Enavate Sciences based?
Enavate Sciences is headquartered in New York City, New York, United States.
When was Enavate Sciences founded?
Enavate Sciences was founded in 2022.
How many portfolio companies does Enavate Sciences have?
Enavate Sciences has 13 portfolio companies in Caplight's dataset.
What are some companies in Enavate Sciences's portfolio?
Portfolio companies visible on Caplight include Braveheart Bio, Sionna, Normunity, AirNexis Therapeutics, CAMP4.
What was Enavate Sciences's most recent investment shown here?
Enavate Sciences's most recent investment in this portfolio sample was in AirNexis Therapeutics in 2026.
What sectors does Enavate Sciences focus on?
Enavate Sciences focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Enavate Sciences focus on?
Enavate Sciences typically invests at the Mid stage.
What is Enavate Sciences's AUM?
Enavate Sciences's assets under management are estimated between $100.0M and $250.0M.